New England Capital Financial Advisors »

Sage Therapeutics shares owned by New England Capital Financial Advisors

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by New England Capital Financial Advisors from 13F filings

Historical chart of New England Capital Financial Advisors investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by New England Capital Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by New England Capital Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5k 134 18.75
2023-12-31 $2.9k 134 21.67
2023-09-30 $2.8k 134 20.58
2023-06-30 $6.3k 134 47.02
2023-03-31 $5.6k 134 41.96
2022-12-31 $5.7k 134 42.57

More positions owned by New England Capital Financial Advisors

Capital Group Growth Etf Shs Creation Uni (CGGR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Capital Grp Fixed Incm Etf T Short Duration (CGSD)
Spdr Ser Tr S&P 600 SMCP GRW (SLYG)
Spdr Ser Tr S&p 600 Smcp Val (SLYV)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Capital Grp Fixed Incm Etf T Municipal Income (CGMU)
Spdr Ser Tr Bloomberg Invt (FLRN)
Columbia Etf Tr Ii Em Core Ex Etf (XCEM)

View all positions for New England Capital Financial Advisors

Top funds holding Sage Therapeutics

Wellington Management Company
Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Cowen And Company
Deutsche Bank Aktiengesellschaft
Palo Alto Investors
Dimensional Fund Advisors
Samlyn Capital
Jacobs Levy Equity Management
Citadel Advisors
T. Rowe Price Associates
Goldman Sachs Group
Fisher Investments
Charles Schwab Investment Management

View all funds holding Sage Therapeutics